Vimpat FDA Approval History
FDA Approved: Yes (First approved October 28, 2008)
Brand name: Vimpat
Generic name: lacosamide
Dosage form: Tablets and Injection
Treatment for: Seizures
Vimpat (lacosamide) is an anti-convulsant drug for the treatment of partial onset seizures in adults with epilepsy.
Development Timeline for Vimpat
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.